Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
LATEST POSTS
- 1
Remains of banker missing since 1999 found on California beach by family looking for seashells - 2Interstellar comet 3I/ATLAS to pass closest to Earth on Friday
- 3I’m a neuroscientist who taught rats to drive − their joy suggests how anticipating fun can enrich human life
- 4Warning for snow and ice extended
- 5I served on the expert committee that advised the government on new dietary guidelines – most of our recommendations were ignored
- Kendall Jenner addresses long-standing rumor about her sexuality
- The 15 Most Motivating TED Discusses All Time
- Most normal matter in the universe isn't found in planets, stars or galaxies – an astronomer explains where it's distributed
- Bondi Beach survivor criticizes police for inaction during terror attack
- NASA wants to build a base on the Moon by the 2030s – how and why it plans to build up to a long-term lunar presence
- ByHeart sued over recalled formula by parents of infants sickened with botulism
- Surveys of Music Collections by Film Stars
- NASA funds new tech for upcoming 'Super Hubble' to search for alien life: 'We intend to move with urgency'
- The most effective method to Beat Dental Tension and Guarantee Customary Exams
